The Latest Headlines at BBNS
Ciena’s (CIEN) “Buy” Rating Reiterated at Rosenblatt Securities
Rosenblatt Securities restated their buy rating on shares of Ciena (NYSE:CIEN – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently have a $720.00 price target on the communications... More of this article »
Nouveau Monde Graphite’s (NMG) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Nouveau Monde Graphite (NYSE:NMG – Free Report) in a report released on Monday, MarketBeat Ratings reports. They currently have a $4.50 price objective on the stock. HC... More of this article »
AIB Group plc (OTCMKTS:AIBRF) Short Interest Update
AIB Group plc (OTCMKTS:AIBRF – Get Free Report) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 379,183 shares, a growth of 715.1% from the July 30th total... More of this article »
Coya Therapeutics’ (COYA) Buy Rating Reiterated at Roth Capital
Roth Capital reaffirmed their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently have a $12.00 price target on the stock. Several... More of this article »
B. Riley Financial Cuts Shift4 Payments (NYSE:FOUR) Price Target to $96.00
Shift4 Payments (NYSE:FOUR – Free Report) had its target price decreased by B. Riley Financial from $120.00 to $96.00 in a report released on Monday morning,Benzinga reports. B. Riley Financial currently has a buy rating on the... More of this article »
BJ’s Wholesale Club (NYSE:BJ) Price Target Raised to $115.00
BJ’s Wholesale Club (NYSE:BJ – Free Report) had its target price lifted by UBS Group from $109.00 to $115.00 in a research report released on Monday morning, MarketBeat.com reports. The firm currently has a buy rating on... More of this article »
Frontdoor (NASDAQ:FTDR) Earns Neutral Rating from Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. initiated coverage on shares of Frontdoor (NASDAQ:FTDR – Free Report) in a research report report published on Monday, MarketBeat reports. The brokerage issued a neutral rating and a $95.00 target price... More of this article »
Banco Santander Brasil (NYSE:BSBR) Cut to “Neutral” at UBS Group
UBS Group downgraded shares of Banco Santander Brasil (NYSE:BSBR – Free Report) from a buy rating to a neutral rating in a research report released on Monday morning, Marketbeat Ratings reports. Several other analysts have also... More of this article »
Jersey Mike’s (NYSE:JMKE) Research Coverage Started at Piper Sandler
Piper Sandler started coverage on shares of Jersey Mike’s (NYSE:JMKE – Free Report) in a research report released on Monday, Marketbeat.com reports. The firm issued an overweight rating and a $29.00 target price on the... More of this article »
Ionic Digital (NASDAQ:IOND) Research Coverage Started at BTIG Research
BTIG Research initiated coverage on shares of Ionic Digital (NASDAQ:IOND – Free Report) in a research report released on Monday morning, Marketbeat reports. The firm issued a buy rating and a $85.00 target price on the stock. Several... More of this article »
Reformation (NYSE:REF) Research Coverage Started at BTIG Research
BTIG Research began coverage on shares of Reformation (NYSE:REF – Free Report) in a research report report published on Monday, Marketbeat reports. The brokerage issued a buy rating and a $20.00 price objective on the stock. REF... More of this article »
BOC Hong Kong (BHKLY) Expected to Release Earnings on Friday
BOC Hong Kong (OTCMKTS:BHKLY – Get Free Report) is expected to be releasing its results after the market closes on Friday, August 28th. Analysts expect BOC Hong Kong to post earnings of $5.57 per share and revenue of $5.0495... More of this article »
AnaptysBio’s (ANAB) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a report issued on Monday,Benzinga reports. The brokerage currently has a $95.00 price target on the biotechnology company’s... More of this article »
